Kura Oncology filed an insider trading transaction disclosure with the SEC, and Jefferies Financial Group provided price targets for the company.
3 reports, 2 independent
Updated Sep 3
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Kura Oncology filed an insider trading transaction disclosure with the SEC, and Jefferies Financial Group provided price targets for the company.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Kura Oncology reported increased institutional holdings via SEC filing.1 source
Kura Oncology insider trading disclosure and analyst price targets.1 source
Keep exploring
The entities involved
-
Kura Oncology
company in La Jolla, United States
Nothing else this week.
-
SEC
Slovak company
Related events
- BKV disclosed insider trading activity via SEC filing, coinciding with rating adjustments and price target changes from Citigroup and Truist Financial.
- Insider trading disclosures filed with the SEC by IRADIMED CORPORATION on July 31, 2026.
- Wix.com filed insider trading disclosures with the SEC on September 3, 2026.
- Benchmark and Booking Holdings disclosed insider trading filings while also restating ratings and raising price targets.
- MAIA Biotechnology, Inc. filed disclosures with the SEC regarding insider trades.
Coverage
Newest first; wire copies grouped- themarketsdaily.comKura Oncology, Inc. $KURA Shares Acquired by Pale Fire Capital SE
- tickerreport.com